Impact of P2Y12 inhibitors on cardiovascular outcomes of Korean acute myocardial infarction patients with baseline thrombocytopenia

BACKGROUND: Antiplatelet therapy is crucial for managing acute myocardial infarction (AMI) and reducing adverse ischemic events after percutaneous coronary intervention (PCI) with drug-eluting stents. However, the ideal P2Y12 inhibitor for patients—particularly East Asians—with AMI and low platelet...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Seok, Jeong, Myung Ho, Cho, Kyung Hoon, Kim, Min Chul, Sim, Doo Sun, Hong, Young Joon, Kim, Ju Han, Ahn, Youngkeun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515375/
https://www.ncbi.nlm.nih.gov/pubmed/36186989
http://dx.doi.org/10.3389/fcvm.2022.921955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515375/
https://www.ncbi.nlm.nih.gov/pubmed/36186989
http://dx.doi.org/10.3389/fcvm.2022.921955

Ejemplares similares